Search research articles
Contact Us
Filters
Showing results (221-230 of 283) with videos related to
Page
of 29
Sort By:
Antimicrobial Agents and Chemotherapy
|
December 30, 2010
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir
Charlotte Charpentier, Bénédicte Roquebert, Olivier Delelis, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 4, 2014
Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers
Natacha Lenuzza, Xavier Duval, Grégory Nicolas, et al.
Archives of Cardiovascular Diseases
|
June 21, 2017
Position paper for the evaluation and management of oral status in patients with valvular disease: Groupe de Travail Valvulopathies de la Société Française de Cardiologie, Société Française de Chirurgie Orale, Société Française de Parodontologie et d'Implantologie Orale, Société Française d'Endodontie et Société de Pathologie Infectieuse de Langue Française
Sarah Millot, Philippe Lesclous, Marie-Laure Colombier, et al.
The European Respiratory Journal
|
August 27, 2021
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study
Alexandre Descamps, Nezha Lenzi, Florence Galtier, et al.
Antimicrobial Agents and Chemotherapy
|
April 3, 2019
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens
Charles Burdet, Nathalie Grall, Morgane Linard, et al.
Frontiers in Microbiology
|
April 20, 2018
Human Genetic Susceptibility to Native Valve <i>Staphylococcus aureus</i> Endocarditis in Patients With <i>S. aureus</i> Bacteremia: Genome-Wide Association Study
Karen Moreau, Alisson Clemenceau, Vincent Le Moing, et al.
BMJ Open
|
September 3, 2018
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial
Charles Burdet, Paul Loubet, Vincent Le Moing, et al.
The Lancet. HIV
|
January 14, 2018
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
Patrick Mercié, Julie Arsandaux, Christine Katlama, et al.
BMC Infectious Diseases
|
September 18, 2013
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials
Odile Launay, Xavier Duval, Serge Fitoussi, et al.
Journal of the American College of Cardiology
|
May 26, 2012
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys
Xavier Duval, François Delahaye, François Alla, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 283) with videos related to
Sort By:
Page
of 29
Antimicrobial Agents and Chemotherapy
|
December 30, 2010
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir
Charlotte Charpentier, Bénédicte Roquebert, Olivier Delelis, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 4, 2014
Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers
Natacha Lenuzza, Xavier Duval, Grégory Nicolas, et al.
Archives of Cardiovascular Diseases
|
June 21, 2017
Position paper for the evaluation and management of oral status in patients with valvular disease: Groupe de Travail Valvulopathies de la Société Française de Cardiologie, Société Française de Chirurgie Orale, Société Française de Parodontologie et d'Implantologie Orale, Société Française d'Endodontie et Société de Pathologie Infectieuse de Langue Française
Sarah Millot, Philippe Lesclous, Marie-Laure Colombier, et al.
The European Respiratory Journal
|
August 27, 2021
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study
Alexandre Descamps, Nezha Lenzi, Florence Galtier, et al.
Antimicrobial Agents and Chemotherapy
|
April 3, 2019
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens
Charles Burdet, Nathalie Grall, Morgane Linard, et al.
Frontiers in Microbiology
|
April 20, 2018
Human Genetic Susceptibility to Native Valve <i>Staphylococcus aureus</i> Endocarditis in Patients With <i>S. aureus</i> Bacteremia: Genome-Wide Association Study
Karen Moreau, Alisson Clemenceau, Vincent Le Moing, et al.
BMJ Open
|
September 3, 2018
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial
Charles Burdet, Paul Loubet, Vincent Le Moing, et al.
The Lancet. HIV
|
January 14, 2018
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
Patrick Mercié, Julie Arsandaux, Christine Katlama, et al.
BMC Infectious Diseases
|
September 18, 2013
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials
Odile Launay, Xavier Duval, Serge Fitoussi, et al.
Journal of the American College of Cardiology
|
May 26, 2012
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys
Xavier Duval, François Delahaye, François Alla, et al.
Page
of 29